Portfolio Companies News
May 17, 2019Camel-IDS appoints Thomas Ramdahl a...
Brussels (Belgium), 17 May 2019 The appointment follows the EUR 37m Series A round and supports the next growth stage The Board now consists of Christina Takke (Chair), Karl Nägler, Mårten Steen, Morten Graugaard Døssing, Ohad Hammer, Jean-Louis Baudhuin, Thomas Ramdah... read more
May 16, 2019Oncopeptides Announces Acceptance o...
May 16, 2019 - Regulatory press release Press releases Stockholm – May 16, 2019 – Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that a total of four abstracts have been accepted for presentation at the 24th Congress of European Hematology Association (EHA) meeting (Ju... read more
May 15, 2019Oncopeptides Announces Melflufen Da...
May 15, 2019 - Regulatory press release Press releases Stockholm – May 15, 2019 – Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that data from its Phase 1/2 O-12-M1 study evaluating melflufen, a lipophilic peptide-conjugated alkylator belonging to the novel class of p... read more
May 15, 2019GenSight Biologics reports positive...
15 May 2019 Press releases Durable improvement in best-corrected visual acuity (BCVA), as GS010-treated eyes sustain +15.4 ETDRS letters equivalent improvement versus baseline and +28.1 ETDRS letters equivalent versus nadir Bilateral improvement continues in key visual... read more
May 14, 2019Altimmune Announces First Quarter 2...
May 14, 2019 at 4:15 PM EDT Conference Call & Webcast Scheduled for Wednesday, May 15, at 8:30am Eastern Time GAITHERSBURG, Md., May 14, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc.(Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced financial results for the ... read more
May 10, 2019Q1 2019 General Market Overview
Since the start in 1996, HealthCap funds have invested in 113 portfolio companies.
42 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.